人类肝臟模型市场规模、份额和成长分析（按产品类型、应用、最终用户和地区划分）—2025-2032年产业预测

全球人类肝臟模型市场规模预计在 2023 年达到 12 亿美元，从 2024 年的 13.8 亿美元成长到 2032 年的 41.2 亿美元，在预测期（2025-2032 年）内复合年增长率为 14.7%。

全球人工肝模型市场正受益于药物毒性测试需求的成长以及动物实验的减少。再生医学领域投资的不断增加，以及3D肝臟模型技术的进步，正在推动製药和生物技术领域精准药物测试替代方案的发展。肝臟相关疾病的普遍性进一步激发了人们对个人化医疗的兴趣。然而，先进肝臟建模技术高成本、熟练专业人员短缺以及模型本身的复杂性等挑战可能会阻碍市场成长。此外，监管方面的挑战和模型检验的不一致也可能限制其在整个行业的应用，从而影响市场渗透率和各地区的预期成长。

全球人工肝模型市场驱动因素

对药物毒性进行精准快速评估的需求日益增长，是推动全球人类肝臟模型市场成长的主要动力。这些模型具有更高的生理相关性和更优的预测准确性，使製药公司能够在研发早期阶段就发现潜在的毒性。因此，候选药物可以更有信心地推进开发平臺。这种能力不仅简化了药物评估流程，还提高了研究结果的整体可靠性，从而促进了製药业的创新和效率提升。向更先进的调查方法的转变凸显了人类肝臟模型在现代药物研发中的重要性。

全球人类肝臟模型市场限制因素

全球人类肝臟模型市场面临先进肝臟模型（例如晶片肝臟技术和3D列印组织）生产和永续性的挑战。专用设备、高技能人员和高品质材料所需的资金可能非常庞大。这造成了成本负担和进入门槛，尤其对于预算有限的小规模实验室和机构而言更是如此。因此，这种经济负担阻碍了市场扩张，限制了发展中地区获得最尖端科技的机会，最终限制了肝臟研究及相关应用领域的发展潜力。

全球人类肝臟模型市场趋势

受3D生物列印和晶片器官技术突破性进展的推动，全球人类肝臟模型市场正经历显着成长。这些创新提高了药物筛检流程的准确性，减少了对动物实验的依赖，并使研究人员能够高精度地模拟复杂的肝臟疾病。这项进步不仅加速了药物发现和开发，还有助于实现个人化治疗策略。随着研究人员对更先进、更可靠的人体相关模型的需求不断增长，对先进肝臟模型的需求预计将持续增加，从而推动该市场显着扩张，并吸引来自生物医学领域各行业的投资。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

人类肝臟模型市场规模（按产品类型和复合年增长率划分）（2025-2032 年）

• 市场概览
• 二维模型
• 3D模型
• 晶片肝臟/微流体模型
• 离体/组织切片模型

人类肝臟模型市场规模（按应用及复合年增长率划分）（2025-2032 年）

• 市场概览
• ADME 测试
• 毒理学/安全性测试
• 疾病建模
• 其他的

人类肝臟模型市场规模（按最终用户划分）及复合年增长率（2025-2032 年）

• 市场概览
• 製药和生物技术公司
• 合约研究组织（CRO）
• 学术和研究机构

人类肝臟模型市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• ATCC
• Merck KGaA
• AcceGen
• ZenBio, Inc.
• Organovo Holdings Inc.
• BioIVT
• InSphero
• CN Bio Innovations Ltd.
• STEMCELL Technologies
• ScienCell Research Laboratories, Inc.
• Emulate, Inc.
• Cyfuse Biomedical KK
• Mimetas
• Cellink
• PhoenixBio Co., Ltd.
• Thermo Fisher Scientific Inc.
• BICO Group
• Kirkstall Ltd.
• MATTEK（The BICO Group）
• HiREL

结论与建议

Global Human Liver Models Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.38 billion in 2024 to USD 4.12 billion by 2032, growing at a CAGR of 14.7% during the forecast period (2025-2032).

The market for global human liver models is gaining momentum, driven by an increasing demand for drug toxicity testing and a shift towards reducing animal experimentation. The rise in investments in regenerative medicine, along with advancements in 3D liver models, enhances the development of precise drug testing alternatives in the pharmaceutical and biotechnology sectors. The prevalence of liver-related diseases further fuels interest in personalized medicine. However, challenges such as high costs of advanced liver model technologies, a shortage of skilled professionals, and the complexity associated with these models can hinder growth. Additionally, regulatory challenges and inconsistencies in model validation may restrict broader industry adoption, impacting market penetration and forecasted growth in various regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Liver Models market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Liver Models Market Segments Analysis

Global Human Liver Models Market is segmented by Product Type, Application, End-User and region. Based on Product Type, the market is segmented into 2D Models, 3D Models, Liver-on-a-Chip / Micro-fluidic Models and Ex-Vivo / Tissue Slice Models. Based on Application, the market is segmented into ADME Studies, Toxicology / Safety Testing, Disease Modelling and Others. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organisations (CROs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Human Liver Models Market

The increasing need for precise and prompt assessment of drug toxicity significantly propels the growth of the global human liver models market. These models provide enhanced physiological relevance and improved predictive accuracy, enabling pharmaceutical companies to detect potential toxicity at earlier stages of development. As a result, drug candidates can advance through the development pipeline with greater assurance. This capability not only streamlines the drug evaluation process but also enhances the overall reliability of findings, thereby fostering innovation and efficiency within the pharmaceutical industry. The shift toward more sophisticated testing methodologies underscores the importance of human liver models in modern drug development.

Restraints in the Global Human Liver Models Market

The Global Human Liver Models market faces challenges related to the production and sustainability of sophisticated liver models, including liver-on-a-chip technologies and three-dimensional printed tissues. The financial investment needed for specialized equipment, a highly skilled workforce, and quality materials can be substantial. This creates barriers, particularly for smaller laboratories or institutions operating with limited budgets, as the costs can be overwhelming. Consequently, this financial strain hinders the market's expansion and reduces access to cutting-edge technologies in less developed areas, ultimately limiting the potential for advancements in liver research and related applications.

Market Trends of the Global Human Liver Models Market

The Global Human Liver Models market is witnessing significant growth driven by breakthroughs in 3D bioprinting and organ-on-a-chip technologies. These innovations enhance the precision of drug screening processes and diminish reliance on animal testing, offering researchers the ability to replicate intricate liver diseases with high fidelity. This evolution not only accelerates drug discovery and development but also supports tailored therapeutic strategies. As researchers increasingly seek more sophisticated and reliable human-relevant models, the demand for advanced liver models is expected to rise, positioning this market for notable expansion and attracting investments from various sectors within the biomedical landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Human Liver Models Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• 2D Models
• 3D Models
• Liver-on-a-Chip / Micro-fluidic Models
• Ex-Vivo / Tissue Slice Models

Global Human Liver Models Market Size by Application & CAGR (2025-2032)

• Market Overview
• ADME Studies
• Toxicology / Safety Testing
• Disease Modelling
• Others

Global Human Liver Models Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organisations (CROs)
• Academic & Research Institutes

Global Human Liver Models Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ATCC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZenBio, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organovo Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSphero
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CN Bio Innovations Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyfuse Biomedical K.K.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mimetas
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellink
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PhoenixBio Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BICO Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirkstall Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MATTEK (The BICO Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiREL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations